Oral formulation of DPP-4 inhibitor plus Quercetin improves metabolic homeostasis in type 1 diabetic rats

This study aimed to investigate the potential of an oral formulation (QV formulation) containing Quercetin and a Dipeptidyl Peptidase-4 Inhibitor (DPP-4 inhibitor), Vildagliptin, in improving metabolic homeostasis in type 1 diabetes model. Female albino Fischer rats were divided into four groups: un...

Descripción completa

Detalles Bibliográficos
Autores principales: Miranda, Pedro Henrique de A., Lacerda, Kissyla Christine Duarte, Araújo, Carolina Morais, Barichello, José Mario, Lima, Wanderson Geraldo, Costa, Daniela Caldeira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192983/
https://www.ncbi.nlm.nih.gov/pubmed/30333575
http://dx.doi.org/10.1038/s41598-018-33727-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192983/
https://www.ncbi.nlm.nih.gov/pubmed/30333575
http://dx.doi.org/10.1038/s41598-018-33727-x

Ejemplares similares